HPC
ARNA

HM Payson & Co’s Arena Pharmaceuticals Inc ARNA Stock Holding History

HM Payson & Co’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-194
Closed -$13K – 1203
2021
Q1 		$13K Hold
194
– – ﹤0.01% 845
2020
Q4 		$15K Sell
194
-54
-22% -$4.05K ﹤0.01% 833
2020
Q3 		$19K Buy
+248
New +$16.5K ﹤0.01% 743

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HM Payson & Co's ARNA Position: Q2 2021 in Review

HM Payson & Co sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2021, closing a stake of 194 shares — an estimated $13K sold.

HM Payson & Co first reported a position in ARNA in Q3 2020 and held it in 3 quarters. The position peaked at $19K in Q3 2020. 237 funds tracked by Wall St. Rank hold ARNA as of Q2 2021.

  • HM Payson & Co reported no remaining Arena Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • HM Payson & Co sold 194 Arena Pharmaceuticals Inc shares in Q2 2021, an estimated $13K.
  • HM Payson & Co first reported a position in Arena Pharmaceuticals Inc in Q3 2020 and held it in 3 quarters.
  • HM Payson & Co's Arena Pharmaceuticals Inc position peaked at $19K in Q3 2020.
  • 237 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2021.

Based on HM Payson & Co's 13F filing for Q2 2021, filed 17 Aug 2021.